Big news for lung cancer patients: the FDA just greenlit Boehringer Ingelheim’s new drug, Hernexeos, for those with a specific genetic mutation who’ve already had treatment. In trials, about 75% of patients saw their tumors shrink or disappear! There’s a new test to see if you qualify, but heads up—there are some serious side effects to watch for. Still, this could be a total game-changer for many! #Health #BodyHealth #LungCancer